Navigation Links
B. Braun Renal Therapies Division Announces Enhanced Offerings for Hemodialysis System
Date:11/15/2011

BETHLEHEM, Pa., Nov. 15, 2011 /PRNewswire/ -- Improving staff efficiency and providing greater safety for renal therapy patients, B. Braun Medical Inc. (B. Braun) announced today the availability of an 1100g Solcart B Cartridge for use with the Dialog+ Hemodialysis System, the leading method used in the treatment of patients with kidney failure.

(Logo: http://photos.prnewswire.com/prnh/20081022/NYW008LOGO)

The 1100g Solcart B cartridge touts the highest volume capacity of any B. Braun Solcart B bicarbonate cartridge, which until now had a maximum volume of 760 grams. In addition to being more economical and producing less waste, the larger size cartridge will allow Solcart B to be used for patients requiring customized therapies.

"B. Braun is adding the 1100g Solcart B cartridge for Dialog+ Hemodialysis Systems to provide customers with a cartridge ideal for customized therapies," said Samuel Amory, Vice President, Medical Technology Division for B. Braun Medical Inc. "The Dialog+ Hemodialysis System continues to incorporate greater convenience for both clinicians and renal therapy patients through advanced products like the 1100g Solcart B cartridge."

The Solcart B cartridge with sodium hydrogen carbonate powder for hemodialysis is a practical alternative to liquid alkaline bicarbonate hemodialysis concentrate and central mixing systems. Benefits include easy piercing, a design for convenient storage prior to use and a user friendly design.

For more information on the Solcart B cartridge for the Dialog+ Hemodialysis System or to request a demonstration please visit www.bbraunusa.com or call 800.848.2066.

About B. Braun

B. Braun is a leading manufacturer of infusion therapy and pain management products with an environmentally-friendly focus. Guided by the company's "Sharing Expertise®" philosophy, B. Braun addresses the critical issues of infection prevention, medication safety and environmental responsibility by promoting best practices that help clinicians reduce medication errors, prevent healthcare-acquired infections (HAIs) and achieve sustainability objectives.

Consistently recognized by Frost & Sullivan and KLAS for its medical technology and support services, B. Braun employees share their knowledge with colleagues and customers to improve working processes in hospitals and medical practices and to enhance the safety of patients and healthcare professionals. For more information, call 800-227-2862, e-mail us at inquiry.us@bbraun.com or visit B. Braun at http://bbraunusa.com/.


'/>"/>
SOURCE B. Braun
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
2. B. Braun Awarded Contract With HealthTrust Purchasing Group to Provide Pain Management Solutions
3. B. Braun and Amerinet Sign to Expand Infusion Therapy Offerings
4. MEDRAD and B. Braun Melsungen AG Collaborate to Promote Breakthrough Medical Treatment for Cardiovascular Disease
5. B. Braun Introduces WHIN(R) Safe Huber Needle
6. B. Braun Infusion Systems Complete Interoperability Test for HIMSS10 Interoperability Showcase
7. B. Braun Renal Therapies Division Announces Availability of Adimea
8. FDA Approves Cefepime for Use In B. Brauns DUPLEX(R) System
9. Health Robotics Re-Acquires CytoCares European Rights from B. Braun Melsungen AG for Undisclosed Consideration
10. New Technology Center Increases B. Brauns Infusion Pump Capacity
11. B. Braun Large Volume Heparin Infusion Solutions Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... CITY, Calif. , March 28, 2017 /PRNewswire/ ... company focused on the development and commercialization of ... pain, announced that the European Medicines Agency (EMA) ... sublingual tablet, 30 mcg) Marketing Authorisation Application (MAA) ... of the MAA is underway. The MAA for ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
(Date:3/28/2017)... , March 28, 2017 The ... reach USD 8.0 billion by 2025, according to a ... incidence of infectious diseases and cancer is expected to ... disease diagnosis over the coming years. In addition, higher ... autologous and allogenic stem cell therapy, due to adverse ...
Breaking Medicine Technology:
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... to be invited to the Siemens Healthineers annual customer education symposium, a world-class ... will take place from March 27 - 31, 2017 at the Atlanta Marriott ...
(Date:3/28/2017)... ... ... Isabella Wentz, PharmD, FASCP, one of the leading thyroid experts of the world, is ... about journey and research recently on a blog and discussed some major aspects of ... deal with thyroid disease. , Dr. Wentz completed her graduation from the Midwestern ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... medical society dedicated to advancing the science and clinical practice of radiosurgery, ... RSSearch Patient Registry, a multi-institutional, observational registry established to standardize data collection ...
(Date:3/28/2017)... ... 28, 2017 , ... Z-Medica, LLC, a leading developer and ... (UPMC) will acquire QuikClot® Bleeding Control Kits® (BCK) to equip up to 1,000 ... efforts by the American College of Surgeons, U.S. Department of Defense, Department of ...
Breaking Medicine News(10 mins):